These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2803542)

  • 41. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus.
    Wilkinson LS; Mittleman G; Torres E; Humby T; Hall FS; Robbins TW
    Behav Brain Res; 1993 Jun; 55(2):143-50. PubMed ID: 8395178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum.
    Canales JJ; Gilmour G; Iversen SD
    Brain Res; 2000 Feb; 856(1-2):176-83. PubMed ID: 10677624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-nucleus accumbens amphetamine: dose-dependent effects on food intake.
    Evans KR; Vaccarino FJ
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1149-51. PubMed ID: 3809216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioural topography in the striatum: differential effects of quinpirole and D-amphetamine microinjections.
    Canales JJ; Iversen SD
    Eur J Pharmacol; 1998 Dec; 362(2-3):111-9. PubMed ID: 9874160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area.
    Druhan JP; Fibiger HC; Phillips AG
    Behav Brain Res; 1990 May; 38(2):175-84. PubMed ID: 2163647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
    Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
    Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization.
    Lynch MR; Carey RJ
    Behav Brain Res; 1989 Feb; 32(1):69-74. PubMed ID: 2495013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors.
    Miller AD; Forster GL; Metcalf KM; Blaha CD
    Neuroscience; 2002; 111(2):351-62. PubMed ID: 11983320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat.
    Desole MS; Miele M; Enrico P; Fresu L; Esposito G; De Natale G; Miele E
    Neurosci Lett; 1992 May; 139(1):29-33. PubMed ID: 1407680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats.
    Wang Z; Rebec GV
    Brain Res; 1993 Nov; 627(1):79-88. PubMed ID: 8293307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule.
    Lorrain DS; Arnold GM; Vezina P
    Behav Brain Res; 2000 Jan; 107(1-2):9-19. PubMed ID: 10628726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression.
    Zhang M; Kelley AE
    Neuroscience; 2000; 99(2):267-77. PubMed ID: 10938432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses.
    Andrews CD; Fernando JC; Curzon G
    Neuropharmacology; 1982 Jan; 21(1):63-8. PubMed ID: 6801538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of d-amphetamine: lack of support for the basal ganglia model.
    Waszczak BL; Martin L; Boucher N; Zahr N; Sikes RW; Stellar JR
    Brain Res; 2001 Nov; 920(1-2):170-82. PubMed ID: 11716823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.